DATE: September 5, 2017
TIME: 8:00AM PT, 11:00AM ET
A recent report indicates that circa 79% of 483 warning letters issued by the FDA to the biopharmaceutical industry in 2016 cited deficiencies in data integrity. The FDA outlines their expectations for quality critical instrumentation in the GMP environment in their 21 CFR Part 11 ruling. This webinar takes a look at how quality-critical on-line Total Organic Carbon (TOC) and conductivity instrumentation can be configured to help companies comply with the FDA’s expectations on data integrity, including the use of Microsoft Active Directory and PDF data export.
Medical Laboratory Technician6%
Clinical Laboratory Scientist2%
Life Science Company2%
Manufacturer - Other1%